Signed · Belgium · Pharma and biotech
Arcturus Therapeutics agrees to acquire myNEO.
Arcturus Therapeutics, based in San Diego, California, signed a definitive agreement on 23 September 2026 to acquire myNEO, an AI-driven drug discovery company in Ghent, Belgium. The deal is subject to customary closing conditions. It was signed on 23 September 2026. It had not completed by 28 October 2026.
Signing 23 September 2026
- Buyer
- Arcturus Therapeutics Holdings Inc. ·San Diego, United States
- Target
- myNEO Therapeutics ·Ghent, Belgium
- Type
- Acquisition
- Announced
- 23 September 2026
- Signed
- 23 September 2026
- Value
- Not disclosed
- People
- Not stated in the release
- Last checked
- 28 October 2026
The people side in Belgium
- Where the deal needs EU merger clearance, the buyer may not implement it before clearance. EU Merger Regulation (Council Regulation (EC) No 139/2004), article 7
- In an asset deal, staff move on their existing terms, and the transfer alone is no ground for dismissal. Acquired Rights Directive (Council Directive 2001/23/EC), articles 3 and 4
- In an asset or business transfer, seller and buyer each inform their staff representatives in good time of the date, reasons, implications and planned measures, and consult on those measures. Acquired Rights Directive (Council Directive 2001/23/EC), article 7
- Depending on the country, undertakings with 50 or more employees, or establishments with 20 or more, inform and consult employee representatives on decisions likely to change work organisation or contractual relations substantially. Information and Consultation Directive (Directive 2002/14/EC), articles 3 and 4
Related deals
- 21 Sep
Adlib Softwareto
Paperboxdeal page: Adlib agrees to acquire PaperboxSigned
not statedSigningDay 100 - 9 Sep
Revvity, Inc.to
Human Cell Designdeal page: Revvity agrees to acquire Human Cell DesignSigned
not statedSigningDay 100 - 9 Sep
Corteva, Inc.to
Globachemdeal page: Corteva and Globachem agree to form a joint ventureSigned
not statedSigningDay 100 - 3 Sep
Resonant Clinical Solutionsto
Creapharm Bioservicesdeal page: Resonant Clinical Solutions acquires Creapharm BioservicesCompleted
not statedSigningDay 100